Thursday, May 17, 2018

AstraZeneca fallopian, peritoneal cancer med gets FDA orphan status

The FDA granted AstraZeneca orphan status for olaparib, both for the treatment of fallopian tube cancer and for the treatment of primary peritoneal cancer.
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.